These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15739768)

  • 21. Thrombolysis in extremital arteries--indications and methods.
    Wellander E; Risberg B
    Ann Chir Gynaecol; 1995; 84(4):341-8. PubMed ID: 8687077
    [No Abstract]   [Full Text] [Related]  

  • 22. Antithrombotic and thrombolytic therapy: from evidence to application: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Schünemann HJ; Cook D; Grimshaw J; Liberati A; Heffner J; Tapson V; Guyatt G
    Chest; 2004 Sep; 126(3 Suppl):688S-696S. PubMed ID: 15383490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboembolism.
    Fitzmaurice D; Hobbs FR; McManus R
    Clin Evid; 2005 Dec; (14):198-215. PubMed ID: 16620405
    [No Abstract]   [Full Text] [Related]  

  • 24. Monitoring clot dissolution during intravenous thrombolysis.
    Ribo M; Molina CA
    Pathophysiol Haemost Thromb; 2006; 35(1-2):63-6. PubMed ID: 16855349
    [No Abstract]   [Full Text] [Related]  

  • 25. Antithrombin III-independent effect of depolymerized holothurian glycosaminoglycan (DHG) on acute thromboembolism in mice.
    Nagase H; Kitazato KT; Sasaki E; Hattori M; Kitazato K; Saito H
    Thromb Haemost; 1997 Feb; 77(2):399-402. PubMed ID: 9157603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical, pharmacologic and clinical properties of new thrombolytic agents].
    Gulba DC
    Internist (Berl); 1996 Jun; 37(6):552-66. PubMed ID: 8767988
    [No Abstract]   [Full Text] [Related]  

  • 27. [The current achievements and problems of thrombolytic therapy].
    Bokarev IN
    Ter Arkh; 1992; 64(10):101-5. PubMed ID: 1485236
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Bates SM; Greer IA; Hirsh J; Ginsberg JS
    Chest; 2004 Sep; 126(3 Suppl):627S-644S. PubMed ID: 15383488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New strategies in the management of venous thromboembolis. International Congress for Vascular Medicine. Graz, Austria, 25-27 June 1998].
    Dtsch Med Wochenschr; 1998 Oct; 123(43 Suppl):1-8. PubMed ID: 9821405
    [No Abstract]   [Full Text] [Related]  

  • 30. Guidelines for the use of thrombolytic therapy. Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Ludlam CA; Bennett B; Fox KA; Lowe GD; Reid AW
    Blood Coagul Fibrinolysis; 1995 May; 6(3):273-85. PubMed ID: 7654941
    [No Abstract]   [Full Text] [Related]  

  • 31. Fibrin-selective thrombolytic therapy with recombinant staphylokinase.
    Collen D; Vanderschueren S; Van de Werf F
    Haemostasis; 1996 Oct; 26 Suppl 4():294-300. PubMed ID: 8979135
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fibrinolysis and thrombolytic therapy under laboratory control].
    Osten W
    Med Lab (Stuttg); 1966 May; 19(5):108-13 contd. PubMed ID: 5982109
    [No Abstract]   [Full Text] [Related]  

  • 33. Respiratory pharmacology. Antithrombotic and fibrinolytic therapy.
    Watson-Williams EJ
    Clin Chest Med; 1986 Sep; 7(3):469-80. PubMed ID: 3533402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Local intravenous thrombolytic therapy and intravascular surgical procedures].
    Roth WD; Lehtola A; Keto P; Albäck A; Lepäntalo M
    Duodecim; 2001; 117(24):2613-8. PubMed ID: 12183823
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thromboembolism and blood coagulation in congestive heart failure].
    Serbin VI; Muratov AA
    Pediatriia; 1991; (2):92-7. PubMed ID: 2057304
    [No Abstract]   [Full Text] [Related]  

  • 36. [Antithrombotic therapy in atrial fibrillation].
    da Costa JT
    Acta Med Port; 1999; 12(7-11):245-54. PubMed ID: 10707462
    [No Abstract]   [Full Text] [Related]  

  • 37. Antithrombotic therapy for venous thromboembolic disease.
    Hyers TM; Agnelli G; Hull RD; Weg JG; Morris TA; Samama M; Tapson V
    Chest; 1998 Nov; 114(5 Suppl):561S-578S. PubMed ID: 9822063
    [No Abstract]   [Full Text] [Related]  

  • 38. Thrombolytic therapy in the management of venous thromboembolism.
    Wenger NK
    J Med Assoc Ga; 1983 Feb; 72(2):121-3. PubMed ID: 6833916
    [No Abstract]   [Full Text] [Related]  

  • 39. Antithrombotic therapy for venous thromboembolic disease.
    Hyers TM; Hull RD; Weg JG
    Chest; 1992 Oct; 102(4 Suppl):408S-425S. PubMed ID: 1395825
    [No Abstract]   [Full Text] [Related]  

  • 40. Antithrombotic therapy for venous thromboembolic disease.
    Hyers TM; Hull RD; Weg JG
    Chest; 1989 Feb; 95(2 Suppl):37S-51S. PubMed ID: 2644102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.